Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioblastoma 5Childhood Brain Neoplasm 2Neurodegenerative Diseases 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Glioma 1Cranial Nerve Diseases 1Central Nervous System Vascular Malformations 1Central Nervous System Neoplasms 1Central Nervous System Infections 1Brain Injuries 1Adult Brain Glioblastoma 1

Interventions

Tissue Array Analysis 1Magnetic Resonance Spectroscopy 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhagic Stroke × Ferrosoferric Oxide × CNS × Clear all
NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡